arrow
L

Luca Cantini

department of medical oncology
H指数:25
被引数:2,271

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Decade of Treating ALK-Rearranged Non-Small Cell Lung Cancer in a Lower Middle-Income Country: Changing Patterns and Improving Survival

十年来在中低收入国家治疗ALK重排非小细胞肺癌:治疗模式的转变与生存改善

2025-10-170
OA
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity

长期接受帕博利珠单抗单药治疗的患者中,具有晚期非小细胞肺癌、PD-L1表达≥50%且体力状况较差者的长期结局:基于Transformer的AI用于表征预后复杂性

2025-10-160
OAAI
First-line pembrolizumab for metastatic NSCLC in lower-middle-income countries: bridging the efficacy-effectiveness gap

一线帕博利珠单抗治疗低收入和中等收入国家转移性非小细胞肺癌:弥合疗效-实效差距

2025-09-050
OA
Unraveling the link between cholesterol and immune system in cancer: From biological mechanistic insights to clinical evidence. A narrative review

解开胆固醇和免疫系统在癌症之间的联系: 从生物学机制的见解到临床证据。叙述性评论

2025-05-010
PRE
Case report: Single gene testing and comprehensive genomic profiling in non-small cell lung cancer-a case series of divergent results from a large reference laboratory
2024-10-310
OAAI
Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy

头颈部鳞状细胞癌的生物标志物: 解开精确免疫疗法的途径

2024-10-080
OAAI
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research
2024-03-011
OAAI
Prospective assessment of nutritional status in patients with advanced non-small cell lung cancer and renal cell carcinoma treated with immune checkpoint inhibitors

免疫检查点抑制剂治疗晚期非小细胞肺癌和肾癌患者营养状况的前瞻性评估

2023-10-010
PRE
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study

延长间隔给药免疫检查点抑制剂的安全性: 一项多中心队列研究

2023-04-124
OAAI
Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study

新型冠状病毒肺炎爆发后晚期乳腺癌发病率上升。来自意大利covid-delay研究的真实数据

BREAST
IF7.9
2022-10-0116
OAAI
Original Research Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry

癌症患者长期新型冠状病毒肺炎后遗症的原始研究持续性: 来自OnCovid注册表的分析

2022-07-0117
OAAI
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario
2022-04-0145
OAAI
Evaluation of COVID-19 impact on DELAYing diagnostictherapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario (vol 7, 100406, 2022)
2022-04-012
OAAI
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status
2022-01-215
OAAI